ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 72 filers reported holding ZAI LAB LTD in Q1 2019. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $412,039 | +54.1% | 14,859 | +70.6% | 0.00% | 0.0% |
| Q4 2022 | $267,397 | -10.3% | 8,710 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $298,000 | -85.5% | 8,710 | -85.3% | 0.00% | -75.0% |
| Q2 2022 | $2,056,000 | +436.8% | 59,307 | +580.9% | 0.00% | +300.0% |
| Q1 2022 | $383,000 | -98.6% | 8,710 | -98.0% | 0.00% | -98.0% |
| Q4 2021 | $27,662,000 | +5.1% | 440,129 | +76.3% | 0.05% | -53.2% |
| Q3 2021 | $26,314,000 | +4024.5% | 249,681 | +6826.0% | 0.11% | +3533.3% |
| Q2 2021 | $638,000 | -92.9% | 3,605 | -94.6% | 0.00% | -93.9% |
| Q4 2020 | $9,016,000 | +12250.7% | 66,617 | +4591.3% | 0.05% | +4800.0% |
| Q1 2020 | $73,000 | +23.7% | 1,420 | 0.0% | 0.00% | – |
| Q4 2019 | $59,000 | +28.3% | 1,420 | 0.0% | 0.00% | – |
| Q3 2019 | $46,000 | -81.6% | 1,420 | -83.3% | 0.00% | -100.0% |
| Q1 2019 | $250,000 | +152.5% | 8,488 | +100.0% | 0.00% | 0.0% |
| Q4 2018 | $99,000 | -99.1% | 4,244 | -99.2% | 0.00% | -97.8% |
| Q3 2018 | $10,640,000 | – | 546,164 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |